Prospective epidemiological studies indicate that a high habitual intake of beverages sweetened with non-caloric artificial sweeteners (NAS) increases the risk of developing type 2 diabetes (T2DM), but the underlying mechanisms are unknown. In animals, acute exposure to NAS activates intestinal sweet taste receptors (STRs) to trigger the release of glucose-dependent insulinotropic polypeptide (GIP) from proximal K-cells, and glucagon-like peptide-1 and 2 (GLP-1, GLP-2) from more distal L-cells, while dietary NAS supplementation increases the function of the sodium-dependent glucose co-transporter-1 (SGLT-1) to augment glucose absorption and increase postprandial glycaemia. It is not known whether NAS alters glucose absorption in humans, and if so, whether this affects postprandial glycaemic control adversely.
